Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03704376 · ClinicalTrials.gov registry record · Phase 4

Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction

A Phase 4 study of Anterior Cruciate Ligament Injury, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 4
Development phase
125
Enrollment target
1
Study location

NCT03704376 is a Phase 4 study of Anterior Cruciate Ligament Injury that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 125 participants, below the 218-participant average among 8 other Anterior Cruciate Ligament Injury trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03704376, a Phase 4 study of Anterior Cruciate Ligament Injury, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 4
Development phase
125 participants
Enrollment target
1
Study location

Study Summary

This study will examine the potential differences between femoral nerve blockade (FNB) and adductor canal blockade (ACB) for pain control and quadriceps muscle activation for patients following anterior cruciate ligament (ACL) reconstruction.

Interventions

  • DRUG 30 ml of 0.2% ropivacaine
  • DRUG 15 ml of 0.2% ropivacaine
  • DRUG 100 mcg clonidine
  • DEVICE High-frequency linear ultrasound transducer

Study Locations (1)

Texas

  • The University of Texas Health Science Center-Houston - Houston

Trial Details

FieldValue
Enrollment Target 125 participants
Start Date 2016-02-01
Est. Completion 2017-11-16
Phase Phase 4

What the Registry Record Tells You About NCT03704376

The ClinicalTrials.gov registry entry for NCT03704376 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 8 other Anterior Cruciate Ligament Injury trials with a reported enrollment target (43% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anterior Cruciate Ligament Injury appearing as the primary indexed condition, and to 4 interventions - of which 30 ml of 0.2% ropivacaine is the first listed.

NCT03704376 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03704376 about?

NCT03704376 is a clinical study titled "Clinical Comparison of Femoral Nerve Versus Adductor Canal Block Following Anterior Ligament Reconstruction". This study will examine the potential differences between femoral nerve blockade (FNB) and adductor canal blockade (ACB) for pain control and quadriceps muscle activation for patients following anterior cruciate ligament (ACL) reconstruction.

What is the current status of trial NCT03704376?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 125 participants. The study started on 2016-02-01. Estimated completion is 2017-11-16.

What conditions does trial NCT03704376 study?

This clinical trial studies the following conditions: Anterior Cruciate Ligament Injury.

What interventions are being tested in trial NCT03704376?

The interventions under investigation include: 30 ml of 0.2% ropivacaine (DRUG), 15 ml of 0.2% ropivacaine (DRUG), 100 mcg clonidine (DRUG), High-frequency linear ultrasound transducer (DEVICE).

Who is sponsoring clinical trial NCT03704376?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03704376 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anterior Cruciate Ligament Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.